XTX Topco’s Axsome Therapeutics AXSM Stock Holding History

XTX Topco’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$557K	Sell	3,297 -28,557	-90%	-$4.93M	0.01%	1942
2025 Q4	$5.82M	Buy	31,854 +30,015	+1,632%	+$4.19M	0.15%	94
2025 Q3	$223K	Buy	+1,839	New	+$207K	0.01%	1757
2025 Q2	–	Sell	-3,357	Closed	-$392K	–	2355
2025 Q1	$392K	Sell	3,357 -9,794	-74%	-$1.12M	0.02%	1211
2024 Q4	$1.11M	Buy	+13,151	New	+$1.21M	0.09%	239
2024 Q3	–	Sell	-11,205	Closed	-$902K	–	2083
2024 Q2	$902K	Buy	11,205 +7,173	+178%	+$531K	0.08%	396
2024 Q1	$322K	Buy	+4,032	New	+$338K	0.04%	793
2023 Q4	–	Sell	-4,388	Closed	-$307K	–	1588
2023 Q3	$307K	Buy	4,388 +1,520	+53%	+$114K	0.05%	716
2023 Q2	$206K	Buy	+2,868	New	+$212K	0.04%	981
2022 Q4	–	Sell	-6,812	Closed	-$304K	–	1120
2022 Q3	$304K	Buy	+6,812	New	+$340K	0.08%	490
2021 Q2	–	Sell	-4,680	Closed	-$265K	–	806
2021 Q1	$265K	Buy	+4,680	New	+$329K	0.13%	341

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

XTX Topco's AXSM Position: Q1 2026 in Review

XTX Topco reduced its Axsome Therapeutics (AXSM) stake by 90% in Q1 2026, selling an estimated $4.93M and leaving 3,297 shares worth $557K. The position accounts for 0.01% of the portfolio, ranked #1942.

XTX Topco first reported a position in AXSM in Q1 2021 and has held it in 11 quarters since. The position peaked at $5.82M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

XTX Topco held 3,297 shares of Axsome Therapeutics worth $557K as of Q1 2026.
XTX Topco sold 28,557 Axsome Therapeutics shares in Q1 2026, an estimated $4.93M.
Axsome Therapeutics made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1942 holding.
XTX Topco first reported a position in Axsome Therapeutics in Q1 2021 and has held it in 11 quarters since.
XTX Topco's Axsome Therapeutics position peaked at $5.82M in Q4 2025.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.